[PREMIERE AT 10:00AM ET] Does the Key to Curing Alzheimer’s and a Rare Childhood Disease Lie in Plasmalogens?
[ad_1]
Could Curing a Rare Childhood Disease Signal Hope for Alzheimer’s Sufferer?
Fifteen years of neuroscientific research led Dr. Dayan Goodenowe to a landmark discovery: a single molecule much lower than normal in the blood of people with Alzheimer’s. Using his own technology, he identified that molecule as plasmalogen—an essential brain nutrient found in mothers’ breast milk. Was Alzheimer’s being caused by its depletion in brain cells?
What would happen if it could be restored? The challenge was set.
Since 2007, Goodenowe has researched and developed a treatment now being trialed by hundreds of doctors across America on Alzheimer’s sufferers. But on the opposite end of the life spectrum, two children with a rare (1 in every 100,000 births) disease are rapidly and profoundly displaying this treatment’s effects.
Witness the changes in the two children, which signal hope not just for their diagnosis, but for treating other serious diseases, including Alzheimer’s—on #Vitalsigns with Brendon Fallon.
You can find out more about Dr. Dayan Goodenowe’s research at: https://drgoodenowe.com/
#dayangoodenowe #sheldonjordan #rcdp #alzheimers #dementia
—————————————————————————————————————————————–
Related research by Dr Goodenowe:
Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer’s disease and dementia
https://www.jlr.org/article/S0022-2275(20)42448-4/fulltext
Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in
a Cross-Sectional Study
https://www.mdpi.com/2076-3425/9/4/92
Plasmalogen deficiency and neuropathology in Alzheimer’s disease: Causation or coincidence?
https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1016/j.trci.2019.08.003
Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species
https://www.frontiersin.org/articles/10.3389/fcell.2022.866156/full
Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons
https://www.frontiersin.org/articles/10.3389/fcell.2022.864842/full
===================================================================================
Vital Signs’ host, guests and contributors offer general information on improving health and wellness. This is not intended as diagnosis or medical advice. You should consult your medical doctor or holistic doctor before enacting any suggested strategies for health and wellness improvement, including those in relation to preventing or treating specific diseases featured on this program.
* Click the “Save” button below the video to access it later on “My List.”
Follow EpochTV on social media:
Twitter: https://twitter.com/EpochTVus
Rumble: https://rumble.com/c/EpochTV
Truth Social: https://truthsocial.com/@EpochTV
Gettr: https://gettr.com/user/epochtv
Facebook: https://www.facebook.com/EpochTVus
Gab: https://gab.com/EpochTV
Telegram: https://t.me/EpochTV
[ad_2]
Source link
